Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Amgen · 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
gastric-cancer
gastric cancer, first line treatment gastroesophageal junction (gej), gastroesophageal junction cancer (gej), gej cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 893739
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.